Structure of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4 and characterization of its interaction with eIF4A

Oncogene

Volumn 26, Issue 34, 2007, Pages 4941-4950

  Waters, L C ^a   Veverka, V ^a   Bohm M ^b   Schmedt, T ^b   Choong, P T ^a   Muskett, F W ^a   Klempnauer, K H ^b   Carr, M D ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

eIF4A; HEAT; MA 3; NMR; Pdcd4; Translation

Indexed keywords

HELIX LOOP HELIX PROTEIN; INITIATION FACTOR 4A; PROGRAMMED CELL DEATH PROTEIN 4; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; COMPARATIVE STUDY; GENE SEQUENCE; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS REGULATORY PROTEINS; BINDING SITES; EUKARYOTIC INITIATION FACTOR-4A; MICE; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, TERTIARY; RNA-BINDING PROTEINS; STRUCTURAL HOMOLOGY, PROTEIN; TUMOR SUPPRESSOR PROTEINS;

EUKARYOTA;

EID: 34547410355     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/sj.onc.1210305     Document Type: Article

References (43)

1. Afonja O, Juste D, Das S, Matsuhashi S, Samuels H. (2004). Induction of PDCD4 tumor suppressor gene expression by RAR agonists, antiestrogen and HER-2/neu antagonist in breast cancer cells. Evidence for a role in apoptosis. Oncogene 23: 8135-8145.
2. Andrade M, Bork P. (1995). HEAT repeats in the Huntingtons-disease protein. Nat Genet 11: 115-116.
3. Bellsolell L, Cho-Park PF, Poulin F, Sonenberg N, Burley SK. (2006). Two structurally atypical HEAT domains in the C-terminal portion of human eIF4G support binding to eIF4A and Mnk1. Structure 14: 913-923.
4. Bitomsky N, Bohm M, Klempnauer K. (2004). Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23: 7484-7493.
5. Bohm M, Sawicka K, Siebrasse J, Brehmer-Fastnacht A, Peters R, Klempnauer K. (2003). The transformation suppressor protein Pdcd4 shuttles between nucleus and cytoplasm and binds RNA. Oncogene 22: 4905-4910.
6. Chen Y, Knosel T, Kristiansen G, Pietas A, Garber M, Matsuhashi S et al. (2003). Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis. J Pathol 200: 640-646.
7. Cmarik J, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H et al. (1999). Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation. Proc Natl Acad Sci USA 96: 14037-14042.
8. Cornilescu G, Delaglio F, Bax A. (1999). Protein backbone angle restraints from searching a database for chemical shift and sequence homology. J Biomol NMR 13: 289-302.
9. Cuff JA, Clamp ME, Siddiqui AS, Finlay M, Barton GJ. (1998). JPred: a consensus secondary structure prediction server. Bioinformatics 14: 892-893.
10. Finn RD, Mistry J, Schuster-Bockler B, Griffiths-Jones S, Hollich V, Lassmann T et al. (2006). Pfam: clans, web tools and services. Nucleic Acids Res 34: D247-51.
11. Groves MR, Barford D. (1999). Topological characteristics of helical repeat proteins. Curr Opin Struct Biol 9: 383-389.
12. Guntert P, Mumenthaler C, Wuthrich K. (1997). Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol 273: 283-298.
13. Herrmann T, Guntert P, Wuthrich K. (2002). Protein NMR structure determination with automated NOE assignment using the new software CANDID and the torsion angle dynamics algorithm DYANA. J Mol Biol 319: 209-227.
14. Hershey JWB, Merrick WC. (2000). Pathway and mechanism of initiation of protein synthesis. In: Sonenberg N, Hershey JWB, and Mathews MB (eds). Translational Control of Gene expression: Pathway and Mechanism of Initiation of Protein Synthesis. Cold Spring Harbor Laboratory Press: New York, pp 33-88.
15. Holm L, Sander C. (1993). Protein structure comparison by alignment of distance matrices. J Mol Biol 233: 123-138.
16. Imataka H, Sonenberg N. (1997). Human eukaryotic translation initiation factor 4G (eIF4G) possesses two separate and independent binding sites for eIF4A. Mol Cell Biol 17: 6940-6947.
17. Jansen A, Camalier C, Stark C, Colburn N. (2004). Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity. Mol Cancer Ther 3: 103-110.
18. Koradi R, Billeter M, Wuthrich K. (1996). MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph 14: 51-55.
19. Laronde-Leblanc N, Santhanam AN, Baker AR, Wlodawer A, Colburn NH. (2007). Structural basis for inhibition of translation by the tumor suppressor Pdcd4. Mol Cell Biol 27: 147-156.
20. Marcotrigiano J, Lomakin I, Sonenberg N, Pestova T, Hellen C, Burley S. (2001). A conserved HEAT domain within elF4G directs assembly of the translation initiation machinery. Mol Cell 7: 193-203.
21. Marintchev A, Wagner G. (2004). Translation initiation: structures, mechanisms and evolution. Q Rev Biophys 37: 197-284.
22. Mazza C, Ohno M, Segref A, Mattaj IW, Cusack S. (2001). Crystal structure of the human nuclear cap binding complex. Mol Cell 8: 383-396.
23. Muskett F, Frenkiel T, Feeney J, Freedman R, Carr M, Williamson R. (1998). High resolution structure of the N-terminal domain of tissue inhibitor of metalloproteinases-2 and characterization of its interaction site with matrix metalloproteinase-3. J Biol Chem 273: 21736-21743.
24. Oberer M, Marintchev A, Wagner G. (2005). Structural basis for the enhancement of eIF4A helicase activity by eIF4G. Genes Dev 19: 2212-2223.
25. Palamarchuk A, Efanov A, Maximov V, Aqeilan R, Croce C, Pekarsky Y. (2005). Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res 65: 11282-11286.
26. Pause A, Methot N, Sonenberg N. (1993). The HRIGRXXR region of the DEAD box RNA helicase eukaryotic translation initiation factor-4A is required for RNA-binding and ATP hydrolysis. Mol Cell Biol 13: 6789-6798.
27. Pause A, Sonenberg N. (1992). Mutational analysis of a DEAD box RNA helicase- The mammalian translation initiation-factor eIF-4A. EMBO J 11: 2643-2654.
28. Ponting CP. (2000). Novel eIF4G domain homologues linking mRNA translation with nonsense-mediated mRNA decay. Trends Biochem Sci 25: 423-426.
29. Renshaw P, Lightbody K, Veverka V, Muskett F, Kelly G, Frenkiel T et al. (2005). Structure and function of the complex formed by the tuberculosis virulence factors CFP-10 and ESAT-6. EMBO J 24: 2491-2498.
30. Renshaw PS, Panagiotidou P, Whelan A, Gordon SV, Hewinson RG, Williamson RA et al. (2002). Conclusive evidence that the major T-cell antigens of the Mycobacterium tuberculosis complex ESAT-6 and CFP-10 form a tight, 1:1 complex and characterization of the structural properties of ESAT-6, CFP-10, and the ESAT-6.CFP-10 complex. Implications for pathogenesis and virulence. J Biol Chem 277: 21598-21603.
31. Rozen F, Edery I, Meerovitch K, Dever T, Merrick W, Sonenberg N. (1990). Bidirectional RNA helicase activity of eukaryotic translation initiation factor-4A and factor-4F. Mol Cell Biol 10: 1134-1144.
32. Shibahara K, Asano M, Ishida Y, Aoki T, Koike T, Honjo T. (1995). Isolation of a novel mouse gene MA-3 that is induced upon programmed cell death. GENE 166: 297-301.
33. Svitkin Y, Pause A, Haghighat A, Pyronnet S, Witherell G, Belsham G et al. (2001). The requirement for eukaryotic initiation factor 4A (eIF4A) in translation is in direct proportion to the degree of mRNA 5′ secondary structure. RNA 7: 382-394.
34. Tanner N, Cordin O, Banroques J, Doere M, Linder P. (2003). The Q motif: a newly identified motif in DEAD box helicases may regulate ATP binding and hydrolysis. Mol Cell 11: 127-138.
35. Waters L, Yue B, Veverka V, Renshaw P, Bramham J, Matsuda S et al. (2006a). Structural diversity in p160/CREB-binding protein coactivator complexes. J Biol Chem 281: 14787-14795.
36. Waters LC, Bohm M, Veverka V, Muskett FW, Frenkiel TA, Kelly GP et al. (2006b). NMR assignment and secondary structure determination of the C-terminal MA-3 domain of the tumour suppressor protein Pdcd4. J Biomol NMR 36: S5:18.
37. Williamson R, Carr M, Frenkiel T, Feeney J, Freedman R. (1997). Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation. Biochemistry 36: 13882-13889.
38. Yamamoto Y, Singh CR, Marintchev A, Hall NS, Hannig EM, Wagner G et al. (2005). The eukaryotic initiation factor (eIF) 5 HEAT domain mediates multifactor assembly and scanning with distinct interfaces to eIF1, eIF2, eIF3, and eIF4G. Proc Natl Acad Sci USA 102: 16164-16169.
39. Yang H, Cho M, Zakowicz H, Hegamyer G, Sonenberg N, Colburn N. (2004). A novel function of the MA-3 domains in transformation and translation suppressor Pdcd4 is essential for its binding to eukaryotic translation initiation factor 4A. Mol Cell Biol 24: 3894-3906.
40. Yang H, Jansen A, Komar A, Zheng X, Merrick W, Costes S et al. (2003a). The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol Cell Biol 23: 26-37.
41. Yang H, Jansen A, Nair R, Shibahara K, Verma A, Cmarik J et al. (2001). A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappa B or ODC transactivation. Oncogene 20: 669-676.
42. Yang H, Knies J, Stark C, Colburn N. (2003b). Pdcd4 suppresses tumor phenotype in JB6 cells by inhibiting AP-1 transactivation. Oncogene 22: 3712-3720.
43. Zakowicz H, Yang H, Stark C, Wlodawer A, Laronde-Leblanc N, Colburn N. (2005). Mutational analysis of the DEAD-box RNA helicase eIF4AII characterizes its interaction with transformation suppressor Pdcd4 and eIF4GI. RNA 11: 261-274.